Published: Apr 10, 2026
Written by Klarity Editorial Team
Published: Apr 10, 2026

If you’re living with bipolar disorder, you know how challenging it can be to maintain consistent access to care and medication. Between work schedules, transportation barriers, and the stigma that sometimes surrounds mental health appointments, getting the treatment you need isn’t always easy. That’s why so many people are turning to telehealth for bipolar disorder management—but is it actually legal to get your mood stabilizers prescribed online?
The short answer: Yes. As of 2025, it is fully legal to receive telehealth treatment for bipolar disorder and have common mood stabilizers like lithium, lamotrigine (Lamictal), and quetiapine (Seroquel) prescribed virtually in all 50 states. Unlike controlled medications that face stricter federal oversight, these essential bipolar medications are not subject to special telehealth restrictions, making virtual care a convenient and compliant option for many patients.
In this comprehensive guide, we’ll walk you through everything you need to know about getting bipolar medication through telehealth—including federal and state regulations, which medications can be prescribed remotely, what to expect during a virtual visit, and how to find safe, legitimate telehealth providers.
You may have heard that federal law requires an in-person visit before prescribing certain medications online. This rule comes from the Ryan Haight Online Pharmacy Consumer Protection Act of 2008, which was designed to prevent illegal online pharmacies from distributing controlled substances like opioids and stimulants without proper medical oversight.
Here’s the key distinction: The Ryan Haight Act only applies to controlled substances—drugs that the DEA classifies as having potential for abuse or dependence (Schedule II-V medications). The most commonly prescribed bipolar mood stabilizers—lithium, lamotrigine, and quetiapine—are NOT controlled substances. This means they fall outside the scope of the Ryan Haight Act’s in-person requirement, and providers can legally prescribe them based solely on a telehealth evaluation.
Even for controlled substances (such as ADHD stimulants or anxiety medications that might be co-prescribed with bipolar treatment), the landscape has evolved significantly. During the COVID-19 public health emergency, the DEA waived the in-person exam requirement for controlled substances prescribed via telehealth. This temporary flexibility has been extended multiple times and is currently in effect through December 31, 2026.
While this extension primarily affects controlled medications, it demonstrates the federal government’s recognition that telehealth can provide safe, effective psychiatric care. For bipolar patients seeking mood stabilizers specifically, the takeaway is clear: there are no federal barriers to virtual prescribing of your medications.
While federal law sets the baseline, individual states have their own telehealth regulations that providers must follow. The good news? No state prohibits telehealth prescribing of non-controlled bipolar medications. However, there are some nuances worth understanding:
Most states—including California, Texas, New York, Florida, Delaware, Illinois, Georgia, and Alabama—allow providers to prescribe mood stabilizers via telehealth without requiring an initial in-person visit. As long as the telehealth encounter meets the standard of care (thorough evaluation, appropriate documentation, informed consent), the prescription is legally valid.
California has been particularly progressive, explicitly allowing telehealth exams to satisfy the ‘appropriate prior examination’ requirement. Proposed legislation (AB 1503) would further clarify that even asynchronous screening tools can be part of the evaluation process.
Texas explicitly permits mental health teleprescribing, making it clear that psychiatric medications can be prescribed through secure video visits without an in-person component.
New York allows telehealth prescribing of non-controlled medications without restrictions. (The state did adopt new rules in 2025 requiring in-person visits for controlled substances in certain circumstances, but this doesn’t affect lithium, lamotrigine, or quetiapine.)
New Hampshire stands out as having a slightly different approach. Under legislation passed in 2025 (SB 252), providers who prescribe medications via ongoing telehealth must conduct an evaluation at least once every 12 months. The good news? This evaluation can still be done via telehealth—it doesn’t have to be in person. This annual check-in ensures continuity of care and gives providers an opportunity to reassess your treatment plan.
One universal rule across all states: Your telehealth provider must be licensed in the state where you’re physically located at the time of the appointment. This means if you live in Florida, your provider needs a Florida medical license, even if they’re seeing you via video from another state.
Platforms like Klarity Health handle this complexity by maintaining networks of licensed providers in multiple states, ensuring you’re always connected with a clinician who can legally treat you in your location.
Let’s look at the specific medications most commonly used for bipolar disorder and their telehealth prescribing status:
DEA Status: Not controlled (unscheduled)
Telehealth Prescribable: ✅ Yes, in all 50 states
Typical Supply: 30-90 days with refills
Lithium remains the gold standard for bipolar disorder treatment, particularly for bipolar I. Because it’s not a controlled substance, there are no federal or state restrictions on telehealth prescribing. Your provider can conduct a comprehensive psychiatric evaluation via video, review your medical history and any existing lab results, and send an electronic prescription to your pharmacy.
Important consideration: Lithium requires regular blood level monitoring to ensure therapeutic dosing and prevent toxicity. A telehealth provider will order these lab tests electronically, which you’ll complete at a local lab facility. The results are then reviewed during follow-up telehealth appointments. This monitoring requirement is a medical best practice, not a legal barrier—it just means you’ll need access to lab services in your area.
DEA Status: Not controlled (unscheduled)
Telehealth Prescribable: ✅ Yes, in all 50 states
Typical Supply: 30-90 days with refills
Lamotrigine is widely prescribed for bipolar depression and mood stabilization. Like lithium, it’s fully prescribable via telehealth nationwide without any special restrictions.
What to expect: Because lamotrigine requires careful dose titration to minimize the risk of serious rash (Stevens-Johnson syndrome), your provider may start with smaller prescription quantities initially (e.g., a starter pack followed by gradual increases). This is standard medical practice for lamotrigine, whether prescribed in person or virtually.
DEA Status: Not controlled (unscheduled)
Telehealth Prescribable: ✅ Yes, in all 50 states
Typical Supply: 30-90 days with refills
Quetiapine is an atypical antipsychotic commonly used for bipolar mania, mixed episodes, and bipolar depression. It’s legally prescribable through telehealth in every state.
Provider considerations: While quetiapine isn’t a controlled substance, it does have some potential for misuse (people sometimes take it off-label for sleep or sedation). Some states track quetiapine in their Prescription Drug Monitoring Programs (PDMP) as a ‘drug of concern.’ Responsible telehealth providers may check the PDMP as a precaution, and they’ll typically want regular follow-ups to monitor effectiveness and side effects (metabolic changes, sedation, etc.).
Most other mood stabilizers and atypical antipsychotics used for bipolar disorder are similarly available via telehealth:
The pattern is clear: core bipolar medications are accessible through telehealth. Only if you’re prescribed controlled substances as adjunct treatment (such as benzodiazepines for acute anxiety or stimulants for comorbid ADHD) would the temporary DEA flexibilities for controlled substances come into play—and even those are currently permitted via telehealth through 2026.
Legitimate telehealth providers don’t just hand out prescriptions after a brief chat. You should expect a comprehensive psychiatric evaluation that meets the same diagnostic standards as an in-person visit. Here’s what a quality telehealth bipolar assessment typically includes:
You’ll complete a detailed questionnaire covering:
During your video appointment (typically 30-60 minutes for an initial evaluation), your provider will:
If your provider determines you meet DSM-5 criteria for bipolar disorder, they’ll document:
This thorough documentation is both a medical and legal requirement—it ensures continuity of care and protects both you and the provider.
If medication is appropriate, your provider will:
Follow-up frequency varies based on your stability and medication. New bipolar diagnoses or medication changes typically require check-ins every 2-4 weeks initially, then monthly to quarterly once stable.
The answer depends on your state’s scope-of-practice laws, but generally, several types of providers can prescribe mood stabilizers through telehealth:
Psychiatrists can prescribe any bipolar medication in all states and are considered the gold standard for complex cases. They have the most extensive training in psychopharmacology and can manage complicated medication regimens.
Nurse practitioners with psychiatric/mental health specialization are increasingly common in telehealth platforms. Their prescribing authority varies by state:
Independent Practice States (30+ states): In states like New York, Arizona, Oregon, New Mexico, and Delaware, psychiatric NPs can prescribe bipolar medications completely independently without physician oversight.
Collaborative Practice States: In states like Texas, Florida, Pennsylvania, and Georgia, NPs need a formal collaborative agreement with a physician. However, they can still fully manage your bipolar treatment, including prescribing all non-controlled mood stabilizers. The collaboration requirement is an administrative formality, not a barrier to care.
Transitional States: California is currently in transition—experienced NPs who meet certain criteria can practice independently under AB 890, while others still work collaboratively.
The important point: In every state, qualified psychiatric NPs can prescribe lithium, lamotrigine, and quetiapine through telehealth, either independently or with appropriate physician collaboration already in place through their telehealth platform.
PAs with psychiatric training can also prescribe bipolar medications in all states, though they universally require some level of physician supervision. Like NPs in collaborative states, this doesn’t prevent them from providing excellent care—it’s just a licensing requirement.
Some family medicine doctors and internal medicine physicians prescribe bipolar medications via telehealth, though many prefer to refer complex cases to psychiatrists or psychiatric NPs. Straightforward bipolar II or well-controlled bipolar I might be managed by an experienced primary care provider.
What matters most: The provider’s experience with bipolar disorder and their comfort level with prescribing and monitoring mood stabilizers, not just their degree type.
At Klarity Health, we’ve designed our platform to make bipolar treatment accessible while maintaining the highest clinical and legal standards:
We maintain a network of licensed psychiatrists and psychiatric nurse practitioners across all 50 states. When you book an appointment, you’re matched with a provider who:
We believe you should know what care costs upfront. Klarity offers:
Our providers don’t just prescribe medication. Your treatment plan may include:
This holistic approach ensures you’re getting the same quality of care you’d receive in a traditional psychiatric practice—just more conveniently.
Telehealth works well for many bipolar patients, but not everyone. Here’s how to determine if it’s right for you:
You’re likely a good fit for telehealth if you:
Consider seeking traditional in-person treatment if you’re experiencing:
Important note: Even if you start with in-person care during a crisis, you can often transition to telehealth for ongoing maintenance treatment once stabilized. The two models can work together across your treatment journey.
The expansion of telehealth has brought both opportunity and risk. Here’s how to identify legitimate versus questionable telehealth services:
✅ Thorough evaluation: Initial appointments are 30+ minutes and include detailed questions
✅ Licensed providers: Clear information about provider credentials and state licensing
✅ No prescription promises: The website doesn’t guarantee you’ll get medication before evaluation
✅ Follow-up required: Regular check-ins are built into the treatment plan
✅ Safety protocols: Discussion of emergency plans, crisis resources, and when to seek urgent care
✅ Laboratory monitoring: For lithium or other drugs requiring labs, the provider orders appropriate tests
✅ Therapy integration: Encouragement or referrals for psychotherapy alongside medication
🚩 Guaranteed prescriptions: ‘Get your medication today!’ promises before any evaluation
🚩 Ultra-brief visits: Initial appointments under 15 minutes
🚩 No video requirement: Text-only or questionnaire-only prescribing
🚩 No follow-up: One-and-done prescribing without ongoing care
🚩 Direct drug shipping: Medications sent from the ‘doctor’ instead of a licensed pharmacy
🚩 Vague credentials: No clear information about who will see you or their qualifications
🚩 Pressure tactics: Pushing you toward specific expensive medications or unnecessary add-ons
The federal government has cracked down on telehealth companies engaging in inappropriate prescribing. In 2024, the DOJ charged executives from telehealth company Done Health with fraud related to ADHD medication prescribing, and Cerebral paid $3.6 million to settle allegations of improper prescription practices. These cases underscore the importance of choosing reputable providers who prioritize patient safety over volume.
You may wonder: ‘Will my telehealth provider check my prescription history?’ Here’s what you should know:
Prescription Drug Monitoring Programs are state databases that track controlled substance prescriptions. They were created to prevent doctor shopping and identify potential prescription drug misuse.
Because lithium, lamotrigine, and quetiapine are not controlled substances, most states do not require PDMP checks before prescribing them. These medications typically don’t even appear in PDMP databases.
However, many responsible telehealth providers voluntarily check the PDMP as a safety measure. Why?
With quetiapine specifically: Some states have added it to PDMP monitoring as a ‘drug of concern’ due to occasional off-label misuse. Providers may check for patterns of concern, but this doesn’t prevent legitimate prescribing.
PDMP access is restricted to licensed healthcare providers and law enforcement in specific investigations. Your telehealth provider must still comply with HIPAA privacy rules and can only use PDMP data for clinical purposes. They cannot share your prescription information without your consent, except as required by law.
One of the most practical questions: ‘Will my insurance cover telehealth for bipolar disorder?’
Good news: Since the COVID-19 pandemic, most insurance plans have been required to cover telehealth mental health services at the same rate as in-person visits. This includes:
What to verify:
Klarity Health is in-network with many major insurance plans, and our team can help verify your coverage before your first appointment.
If you don’t have insurance or prefer not to use it, Klarity offers transparent self-pay pricing. Our rates are clearly posted, so you know exactly what you’ll pay before booking—no surprise bills.
The prescription itself is separate from the provider visit cost. Bipolar medications vary widely in price:
Many pharmacies offer discount programs (GoodRx, RxSaver) that can significantly reduce costs for self-pay patients.
The telehealth landscape continues to evolve. Here’s what’s on the horizon:
The current telehealth flexibilities for controlled substances are temporary (expiring December 31, 2026). The DEA has proposed permanent rules, and Congress is considering the Telehealth Modernization Act to establish a long-term framework. While this primarily affects controlled medications, the outcomes will shape the broader telehealth environment.
For bipolar patients: Even if temporary flexibilities end, your access to mood stabilizers via telehealth won’t change—these medications were never subject to the restrictions in the first place.
Technology is making it easier to monitor medication response remotely. Emerging tools include:
There’s growing momentum for interstate licensure compacts that would allow providers to more easily practice across state lines. The Psychology Interjurisdictional Compact (PSYPACT) already does this for psychologists; similar models may expand to other mental health providers.
This could make it easier to continue care if you move or travel frequently.
Let’s clear up some misconceptions:
Myth 1: ‘Online doctors can’t prescribe real medications.’
Reality: Telehealth providers with proper licenses prescribe the exact same FDA-approved medications as in-person doctors. Your lithium prescription from a telehealth psychiatrist is identical to one from a traditional practice.
Myth 2: ‘Telehealth is just a questionnaire—you don’t see a real doctor.’
Reality: Legitimate telehealth requires a live video appointment with a licensed provider who conducts a full psychiatric evaluation. Questionnaire-only prescribing is not appropriate for bipolar disorder and is often illegal.
Myth 3: ‘Mood stabilizers are narcotics, so getting them online is sketchy.’
Reality: Lithium, lamotrigine, and quetiapine are NOT narcotics or controlled substances. They’re in the same legal category as antidepressants—medications that require a prescription and professional oversight but aren’t classified as having abuse potential.
Myth 4: ‘Telehealth means lower quality care.’
Reality: Research shows telehealth mental health services produce outcomes comparable to in-person treatment when delivered by qualified providers. Good telehealth platforms often provide more comprehensive care because they emphasize safety protocols, therapy integration, and regular monitoring.
Myth 5: ‘It’s illegal to prescribe psychiatric meds without meeting the patient in person.’
Reality: This is false for non-controlled medications. The in-person requirement (from the Ryan Haight Act) applies only to controlled substances, and even that has been temporarily waived through 2026. For bipolar mood stabilizers specifically, there has never been a federal in-person requirement.
To get the most out of virtual care:
Even though you’re meeting virtually, you can build a solid therapeutic relationship:
Telehealth is excellent for ongoing management but isn’t appropriate for psychiatric emergencies. Go to an emergency room or call 988 (Suicide & Crisis Lifeline) if you experience:
Your telehealth provider should give you clear guidance on when to seek emergency care and who to contact. This emergency plan is a critical part of safe telehealth treatment.
If you’ve been wondering whether you can legally and safely get treatment for bipolar disorder through telehealth, the answer is a definitive yes. The medications you need—lithium, lamotrigine, quetiapine, and others—are fully prescribable via telehealth without legal restrictions. Federal law permits it, state laws support it, and growing research confirms that telehealth can deliver quality mental health care.
Key takeaways:
The barrier to bipolar treatment shouldn’t be logistics. Whether you struggle with transportation, live in an area with few mental health providers, need to fit appointments around work, or simply prefer the convenience of virtual care, telehealth offers a legitimate path to evidence-based treatment.
If you’re considering telehealth treatment for bipolar disorder, Klarity Health can connect you with licensed, experienced providers in your state who can prescribe and manage the full range of bipolar medications. Our platform combines:
Living with bipolar disorder is challenging enough. Getting treatment shouldn’t add to that burden. Telehealth makes quality psychiatric care more accessible—and it’s completely legal and safe when delivered by qualified providers.
Take the first step toward stability. Schedule a telehealth evaluation today and discover how convenient, professional bipolar treatment can fit into your life.
U.S. Department of Health and Human Services. ‘HHS and DEA Extend Telemedicine Flexibilities for Prescribing Controlled Medications Through 2026.’ HHS.gov Press Release, January 2, 2026. www.hhs.gov
Drug Enforcement Administration. ‘DEA Extends Telemedicine Flexibilities to Ensure Continued Access to Care.’ DEA Press Release, December 31, 2025. www.dea.gov
Sheppard Mullin Richter & Hampton LLP. ‘Telehealth and In-Person Visits: Tracking Federal and State Updates on Pandemic-Era Flexibilities.’ JD Supra, August 15, 2025. www.jdsupra.com
Texas Board of Nursing. ‘Advanced Practice Registered Nurse (APRN) Frequently Asked Questions.’ Texas Board of Nursing, accessed December 2025. www.bon.texas.gov
NursePractitionerOnline.com. ‘2025 Nurse Practitioner Practice Authority Updates by State.’ Nurse Practitioner Online, October 3, 2025. www.nursepractitioneronline.com
Find the right provider for your needs — select your state to find expert care near you.